Technology areas: Chemistry & Materials • Transportation, E-Commerce & Mechanical Systems
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Travera, Inc. currently manages 2 pending office actions within the Chemistry & Materials technology area. These actions are assigned to 2 distinct examiners and are being processed in 2 distinct art units. This distribution shows that the company's active patent prosecution is split between different administrative groups, each with its own examination standards. A decentralized approach like this requires the applicant to adapt to multiple procedural environments.
JARRETT, LORE RAMILLANO is the busiest examiner for this portfolio, overseeing 1 pending office action. This single action represents 1 of the 2 pending office actions currently active for the company. With the workload divided between multiple examiners, the company must maintain separate prosecution strategies tailored to the specific art units involved in the Chemistry & Materials sector. Monitoring the progress of both applications will be necessary to ensure overall portfolio growth.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (50%) |
| §101 + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JARRETT, LORE RAMILLANO | 1 | 68.6% | +25.1% |
| COLEMAN, CHARLES P. | 1 | 16.0% | +19.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | JARRETT, LORE RAMILLANO | 114d overdue |
| 16739814 | MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS | COLEMAN, CHARLES P. | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | JARRETT, LORE RAMILLANO | 114d overdue |
| 16739814 | MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS | COLEMAN, CHARLES P. | 15d |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| 3683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17732769 | CALIBRATION OF A FUNCTIONAL BIOMARKER INSTRUMENT | JARRETT, LORE RAMILLANO | 1797 | §101§103§112DP | Non-Final OA | 114d overdue | Pending | Apr 29, 2022 |
| 16739814 | MACHINE LEARNING IN FUNCTIONAL CANCER ASSAYS | COLEMAN, CHARLES P. | 3683 | §101 | Final Rejection | 15d | Pending | Jan 10, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTravera, Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Lore Ramillano Jarrett has the most, with 1 of Travera, Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
